Targeted Cancer Therapies
Tumor Immunotherapy
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Yi Teng1, Yuhang Chen2, Xinyi Tang3
1Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China; Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
氨基氨基酸减小酶2 (PAD2) 通过化蛋白和免疫细胞驱动瘤的进展. PAD2 抑制剂对抗癌症治疗具有前景,尽管仍存在挑战.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: